acetylcysteine has been researched along with Cytokine Release Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albuquerque, GR; Carlos, RSA; Clarindo, FA; Coelho Dos Reis, JGA; da Conceição, AO; da Mata, CPDSM; da Silva, MF; de Carvalho, LD; de Lemos, APML; de Melo Oliveira, P; Dias, JCT; Dos Santos, UR; Fehlberg, HF; Ferreira, FB; Ferreira, GM; Ferreira, LL; Filho, HPP; Fontana, R; Gadelha, SR; Goulart, GAC; Gross, E; Lopes, ATS; Lourenço, AA; Maciel, BM; Mariano, APM; Marin, LJ; Marques, DPA; Martins Filho, OA; Morris, DL; Oliveira, NRR; Quadros, CA; Rezende, RP; Ribeiro, ÁL; Romano, CC; Santana, ÍTS; Santiago, MG; Silva, MM; Sodré, MMD; Valle, SJ | 1 |
| Attalla, M; Chen, B; Daniel, N; Kang, S; Patel, M; Patel, R; Philips, M; Pierre-Louis, F; Raja, K | 1 |
| Wu, J | 1 |
| Goldenberg, R; Ibrahim, H; Kon, Z; Lewis, T; Perl, A; Smith, D; Staniloae, C; Williams, M; Yarta, K | 1 |
| Das, S; Meher, BR; Mohanty, RR; Padhy, BM | 1 |
2 review(s) available for acetylcysteine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Tackle the free radicals damage in COVID-19.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence.
Topics: Acetylcysteine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Prognosis; SARS-CoV-2 | 2021 |
3 other study(ies) available for acetylcysteine and Cytokine Release Syndrome
| Article | Year |
|---|---|
Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bromelains; Chemokines; COVID-19; Cytokine Release Syndrome; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Drug Combinations; Expectorants; Female; Humans; Inflammation Mediators; Male; Middle Aged; Respiration, Artificial; Rheology; SARS-CoV-2; Sputum; Trachea; Young Adult | 2022 |
Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series.
Topics: Acetylcysteine; COVID-19; Cytokine Release Syndrome; Glutathione; Glutathione Reductase; Humans; NF-kappa B; Retrospective Studies; SARS-CoV-2 | 2023 |
Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
Topics: Acetylcysteine; Adult; Antioxidants; Antirheumatic Agents; Betacoronavirus; Biomarkers; C-Reactive Protein; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Administration Schedule; Ferritins; Fibrin Fibrinogen Degradation Products; Glucosephosphate Dehydrogenase Deficiency; Humans; Hydroxychloroquine; Inflammation; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |